Le lenacapavir, dont le Kenya a commencé à administrer les premières doses, est un nouveau traitement prometteur de prévention du VIH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results